Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design.
Bohl, C.E., Wu, Z., Miller, D.D., Bell, C.E., Dalton, J.T.(2007) J.Biol.Chem. 282: 13648-13655
- PubMed: 17311914 
- DOI: 10.1074/jbc.M611711200
- PubMed Abstract: 
Cyproterone acetate (CPA) is a steroidal antiandrogen used clinically in the treatment of prostate cancer. Compared with steroidal agonists for the androgen receptor (AR) (e.g. dihydrotestosterone, R1881), CPA is bulkier in structure and therefore se ...